P. L’allier

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
P. L′allier, Philippe L L'allier, Philippe L’allier, P L L'allier, P. L. L'allier, Philippe L L’allier, Philippe L'allier, Philippe L. L'allier, Philippe L. L’allier
Publication record
198 papers · 8,818 citations · H-index 41

PAPERS

Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.
20260 citationsauthor #22
RISK SCORE FOR FUTURE MYOCARDIAL INFARCTION AFTER AN ACUTE CORONARY SYNDROME AND PHARMACOGENETIC RESPONSE TO DALCETRAPIB
20250 citationsauthor #9
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy
202528 citationsauthor #39
Clinical Deployment of Real-Time Left Ventricular Ejection Fraction Estimation from Coronary Angiography
20250 citationsauthor #33
Mechanism and Imaging of Anomalous Origin of the Right Coronary Artery Resulting in Myocardial Ischemia in the Left Coronary Artery Territory.
20250 citationsauthor #4
Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT).
202443 citationsauthor #20
IMPACT OF MULTIPLE LIFESTYLE INTERVENTIONS ON METABOLIC HEALTH AND REMISSION OF PREDIABETES AND TYPE 2 DIABETES: A TWO-YEAR CLINICAL EXPERIENCE
20234 citationsauthor #17
Evaluation of polygenic score for hypertrophic cardiomyopathy in the general population and across clinical settings
202312 citationsauthor #61
Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy
202331 citationsauthor #34
Metabolic Improvements and Remission of Prediabetes and Type 2 Diabetes: Results From a Multidomain Lifestyle Intervention Clinic.
20226 citationsauthor #14
Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study
202280 citationsauthor #8
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial
202226 citationsauthor #10
Septal myectomy in the era of genetic testing
20211 citationsauthor #6
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT
202115 citationsauthor #28
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
2021238 citationsauthor #46
A Rare Case of Coronary Artery Dilatation and Giant Pseudoaneurysm
20211 citationsauthor #6
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
202192 citationsauthor #3
Peripheral Interventions Radiation Exposure Reduction Using a Sensor-Based Navigation System: A Proof-of-Concept Study
20211 citationsauthor #1
Genetics of symptom remission in outpatients with COVID-19
20216 citationsauthor #29
RACIAL DISPARITIES IN ACUTE CORONARY SYNDROME MANAGEMENT WITHIN THE CANADIAN UNIVERSAL HEALTHCARE SYSTEM: INSIGHTS FROM THE AMI-OPTIMA TRIAL
20210 citationsauthor #10
Racial Disparities in Acute Coronary Syndrome Management Within a Universal Healthcare Context: Insights From the AMI-OPTIMA Trial
20211 citationsauthor #15
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
2021208 citationsauthor #3
Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
20204 citationsauthor #1
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
202074 citationsauthor #21
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
2020263 citationsauthor #23
Abstract 13433: Predictors of Contrast Induced Nephropathy in Patients With Acute Coronary Syndromes and Normal Baseline Glomerular Filtration Rate
20200 citationsauthor #12
In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes
201921 citationsauthor #13
WHAT DOES GENETIC TESTING TELL US ABOUT OUTCOMES IN PATIENTS UNDERGOING SEPTAL MYECTOMY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY?
20190 citationsauthor #6
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
20192,101 citationsauthor #23
Perioperative Right Ventricular Pressure Monitoring in Cardiac Surgery.
201945 citationsauthor #8
Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden.
201816 citationsauthor #9
Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians
20187 citationsauthor #15
Titre : Title : Validating intravascular imaging with serial optical coherence tomography and confocal fluorescence microscopy
20180 citationsauthor #15
INDEPENDENT PREDICTORS OF LIPID-LOWERING THERAPY INTENSIFICATION AMONG PATIENTS HOSPITALIZED FOR AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE AMI-OPTIMA STUDY
20180 citationsauthor #11
Myocardial revascularization: symptomatic and prognostic indications
20180 citationsauthor #2
Selective angiogram of the LIMA anastomosed to the LAD, showing collateralization (Rentrop grade 1) of the RCA postero-lateral branches through septal perforator arteries
20171 citationsauthor #3
Bioresorbable Vascular Scaffold During ST-Elevation Myocardial Infarction: A Systematic Review.
201710 citationsauthor #5
ST-segment elevation myocardial infarction (STEMI) : mid-term outcomes
20170 citationsauthor #4
Selective angiogram of the LCA showing left main stenosis, severe mid-LAD stenosis with competitive flow from LIMA and developed septal branches. Note that collaterals to RCA are not clearly visualized on native LCA angiogram
20171 citationsauthor #3
CONTEMPORARY INCIDENCE OF MURAL THROMBUS FOLLOWING ACUTE ANTERIOR STEMI COMPLICATED BY NEW ANTERO/APICAL WALL MOTION ABNORMALITIES: INSIGHTS FROM THE MULTICENTER MAGIC REGISTRY
20171 citationsauthor #15
MANAGEMENT OF STEMI WITH ANTERIOR WALL MOTION ABNORMALITIES USING TRIPLE VERSUS DOUBLE ANTI-THROMBOTIC THERAPY: THE MAGIC MULTICENTER RETROSPECTIVE REGISTRY
20171 citationsauthor #15
TEE aspect, in mid-esophageal long axis view (140°), of the interventricular septum after alcohol injection in the target septal perforator artery
20171 citationsauthor #3
Effect of treatment with 5‐lipoxygenase inhibitor VIA‐2291 (atreleuton) on coronary plaque progression: a serial CT angiography study
201741 citationsauthor #4
Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome
201713 citationsauthor #15
Selective angiogram of RCA showing a chronic total occlusion of its proximal portion with presence of bridging collaterals
20171 citationsauthor #3
Early Multiple Coronary Micro Aneurysms After Bioresorbable Vascular Scaffold Implantation.
20173 citationsauthor #2
Everolimus‐eluting bioresorbable vascular scaffold implantation to treat saphenous vein graft disease, single‐center initial experience
20173 citationsauthor #8
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy in a patient with a chronic total occlusion of the right coronary artery: "beware of collateral damage".
20170 citationsauthor #3
The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction.
20173 citationsauthor #2
Bioresorbable vascular scaffold to treat in‐stent restenosis: Single‐center experience
20171 citationsauthor #8
Effect of stenosis eccentricity on the functionality of coronary bifurcation lesions—a numerical study
20179 citationsauthor #3
MYOCARDIAL INFARCTION WITH LEFT BUNDLE BRANCH BLOCK: A DEADLY DISEASE WITH A LOW RATE OF REPERFUSION TREATMENT
20170 citationsauthor #10
A COMPARISON OF QUALITY OF CARE OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION BY CHOICE OF REPERFUSION STRATEGY: RESULTS OF A QUÉBEC-WIDE, SYSTEMATIC FIELD EVALUATION (2013-14)
20160 citationsauthor #11
Validating Intravascular Imaging with Serial Optical Coherence Tomography and Confocal Fluorescence Microscopy
20169 citationsauthor #15
Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG Trial.
201644 citationsauthor #13
Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial
201620 citationsauthor #5
Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation
201659 citationsauthor #10
Imaging and functional assessment of bioresorbable scaffolds.
20163 citationsauthor #3
Outcomes of Patients With ST-Elevation Myocardial Infarction Receiving and Not Receiving Reperfusion Therapy: The Importance of Examining All Patients.
201614 citationsauthor #5
Low-dose rubidium-82 3D PET versus thallium-201 SPECT myocardial perfusion imaging for detection of coronary artery disease
20160 citationsauthor #6
RECURRENT ISCHEMIC CARDIO/CEREBROVASCULAR EVENTS AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUEBEC REGISTRY
20160 citationsauthor #13
Erratum: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage after Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction: Results of the SELECT-ACS Trial (Journal of the American College of Cardiology (2013) 61 (2048-2055))
20160 citationsauthor #15
Bioresorbable Scaffolds: The Revolution in Coronary Stenting?
20164 citationsauthor #2
Cardiomyopathy : Miguel A. Barrero Garcia Anthony Ralph-Edwards and George Djaiani
20160 citationsauthor #4
Epidemiology, Management Strategies, and Outcomes of Patients With Chronic Total Coronary Occlusion.
2016139 citationsauthor #8
Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance
201687 citationsauthor #6
BIMODAL INTRAVASCULAR ULTRASOUND (IVUS)/NEAR-INFRARED FLUORESCENCE (NIRF) MOLECULAR IMAGING OF ATHEROSCLEROTIC RABBITS
20160 citationsauthor #10
Clinical Profiles Related to Timing of Death, Including In-Hospital Deaths Before Admission, in Patients With ST-Elevation Myocardial Infarction.
20163 citationsauthor #2
REAL-WORLD CLINICAL OUTCOMES ACCORDING TO DUAL ANTI-PLATELET THERAPY REGIMEN AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: SINGLE CENTER EXPERIENCE IN CANADA
20150 citationsauthor #2
LONGTERM RECURRENT ISCHEMIC CARDIOVASCULAR EVENTS AMONG PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUÉBEC REGISTRY
20150 citationsauthor #13
Bioresorbable vascular scaffold thrombosis in an all-comer patient population: single-center experience.
201525 citationsauthor #2
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
20158 citationsauthor #3
LONG-TERM STATIN USE AND ADHERENCE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE AMI-QUÉBEC REGISTRY
20150 citationsauthor #13
A numerical investigation of the functionality of coronary bifurcation lesions with respect to lesion configuration and stenosis severity.
201512 citationsauthor #3
Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib
2015158 citationsauthor #10
Novel anti-inflammatory therapies for the treatment of atherosclerosis.
2015127 citationsauthor #4
PRIMARY ANGIOPLASTY TREATMENT DELAYS AFTER THE IMPLEMENTATION OF A PROVINCE-WIDE PREHOSPITAL ECG PROGRAM
20150 citationsauthor #10
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access: The Campeau Radial Paradox.
201589 citationsauthor #18
Abstract 213: Treatment Delays in Patients with ST-Elevation Myocardial Infarction Across All Hospitals Performing Primary Percutaneous Coronary Intervention in Quebec, Canada: Results of a Third Field Evaluation
20151 citationsauthor #5
TREATMENT DELAYS ON HOURS VERSUS OFF HOURS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION ACROSS ALL HOSPITALS PERFORMING PRIMARY ANGIOPLASTY IN QUÉBEC, CANADA: RESULTS OF A THIRD FIELD EVALUATION
20150 citationsauthor #5
IM QUÉBEC: A STEMI DATABASE - UNIVERSITY OF MONTRÉAL INTEGRATED HEALTH NETWORK QUALITY ASSURANCE INITIATIVE: REPERFUSION DELAYS AND IN-HOSPITAL OUTCOMES OVER THE FIRST 4 YEARS OF UTILISATION
20150 citationsauthor #2
KNOWLEDGE TRANSLATION TO REDUCE DELAYS OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION: INSIGHTS FROM THE AMI-ON TIME STUDY
20150 citationsauthor #4
Direct stenting versus pre-dilation in ST-elevation myocardial infarction: a systematic review and meta-analysis.
201532 citationsauthor #4
TCT-520 Real-world Clinical Outcomes of Bioresorbable Vascular Scaffold Versus Conventional Drug Eluting Stents in Primary-PCI for ST-elevation Myocardial Infarction: single center one-year experience
20150 citationsauthor #2
KNOWLEDGE TRANSLATION TO IMPROVE PRESCRIPTION OF EVIDENCE-BASED MEDICAL THERAPY FOR PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE AMI-OPTIMA STUDY
20152 citationsauthor #12
Effect of radial-to-femoral access crossover on adverse outcomes in primary percutaneous coronary intervention.
201417 citationsauthor #6
A Novel Minimally Invasive Approach for Surgical Septal Myectomy.
201414 citationsauthor #6
TCT-17 Direct versus conventional stenting in ST-elevation myocardial infarction: a systematic review and meta-analysis
20140 citationsauthor #4
TCT-626 Expanding Indications of Bioresorbable Scaffolds: Single Center Procedural and In-Hospital Outcomes with the first 500 Implanted Devices in a Diversified, All-Comer Patient Population
20140 citationsauthor #1
TCT-54 Additive Prognostic Value Of The Global Registry Of Acute Coronary Events Score Over Other Risk Scores For In-Hospital Outcome Prediction In Patients Presenting With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
20140 citationsauthor #6
Cap buckling as a potential mechanism of atherosclerotic plaque vulnerability.
20144 citationsauthor #5
Transient right internal thoracic arterial graft kink related to respiratory movements: Documentation of its existence, relevance and proposed management
20142 citationsauthor #2
Near-infrared spectroscopy for cardiovascular risk assessment? Not ready for prime time.
20140 citationsauthor #2
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
2014244 citationsauthor #11
REAL-WORLD COST-EFFECTIVENESS OF THE MITRACLIP FOR THE TREATMENT OF HIGH RISK MITRAL REGURGITATION
20140 citationsauthor #7
Real-World Cost Effectiveness Of The Mitraclip For The Treatment Of High-Risk Mitral Regurgitation
20141 citationsauthor #8
TCT-846 Radial-to-femoral access crossover is not associated with adverse outcomes in the setting of primary percutaneous coronary intervention
20140 citationsauthor #6
Abstract 82: Comparison of Outcomes by Type of Treatment for Patients with ST-Elevation Myocardial Infarction (STEMI) who presented to Hospitals without Percutaneous Coronary Intervention (PCI) Facilities in Quebec, Canada
20130 citationsauthor #7
Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network.
201340 citationsauthor #7
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
2013205 citationsauthor #15

TIMELINE

2000 259 citations

2001 103 citations

2002 488 citations

2003 245 citations

2004 465 citations

2005 78 citations

2006 149 citations

2007 1,001 citations

2008 351 citations

2009 363 citations

2010 347 citations

2011 4 citations

2012 197 citations

2013 252 citations

2014 282 citations

2015 454 citations

2016 382 citations

2017 89 citations

2018 23 citations

2019 2,167 citations

2020 341 citations

2021 563 citations

2022 112 citations

2023 47 citations

2024 43 citations

2025 28 citations

2026 0 citations

Unknown 0 citations

P. L’allier

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT